尚荣医疗
(002551)
| 流通市值：16.54亿 | | | 总市值：22.89亿 |
| 流通股本：6.10亿 | | | 总股本：8.45亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,192,887,048.61 | 918,797,662.29 | 599,975,375.76 | 309,400,196.89 |
| 营业收入 | 1,192,887,048.61 | 918,797,662.29 | 599,975,375.76 | 309,400,196.89 |
| 二、营业总成本 | 1,211,329,549.79 | 918,583,909.67 | 598,090,220.95 | 305,917,592.32 |
| 营业成本 | 995,282,795.69 | 745,247,517.01 | 482,688,687.88 | 249,556,083.8 |
| 税金及附加 | 20,138,186.58 | 14,659,229.12 | 9,449,468.74 | 4,548,301.82 |
| 销售费用 | 24,098,710.15 | 14,364,132.26 | 9,423,944.79 | 8,414,632.6 |
| 管理费用 | 141,319,719.97 | 119,052,651.67 | 80,558,851.08 | 43,742,236.04 |
| 研发费用 | 40,074,275.99 | 30,374,558.83 | 18,832,181.07 | 2,172,817.23 |
| 财务费用 | -9,584,138.59 | -5,114,179.22 | -2,862,912.61 | -2,516,479.17 |
| 其中:利息费用 | 2,001,956.99 | 1,839,499.64 | 989,908.15 | 262,064.46 |
| 其中:利息收入 | 8,729,753.29 | 4,875,339.62 | 2,721,005.02 | 1,202,894.93 |
| 加:公允价值变动收益 | -556,449.88 | -46,898.86 | 865,296.4 | 349,496.8 |
| 加:投资收益 | 8,612,757.89 | 2,298,432.59 | -4,037,720.08 | -59,807.51 |
| 资产处置收益 | -25,231.07 | - | - | - |
| 资产减值损失(新) | -67,290,056.12 | - | - | - |
| 信用减值损失(新) | -51,661,112.73 | 2,546,085.61 | -1,576,345.06 | 3,049,042.58 |
| 其他收益 | 8,139,125.1 | 5,965,492.97 | 4,099,987.15 | 959,412.81 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -121,223,467.99 | 10,976,864.93 | 1,236,373.22 | 7,780,749.25 |
| 加:营业外收入 | 2,939,562.36 | 10,962,960.97 | 10,650,021.02 | 711,584.76 |
| 减:营业外支出 | 9,360,918.41 | 3,520,666.57 | 1,062,799.27 | 218,591.25 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -127,644,824.04 | 18,419,159.33 | 10,823,594.97 | 8,273,742.76 |
| 减:所得税费用 | 33,178,991.43 | -506,209.32 | -913,413.37 | 512,688.16 |
| 六、净利润 | -160,823,815.47 | 18,925,368.65 | 11,737,008.34 | 7,761,054.6 |
| 持续经营净利润 | -160,823,815.47 | 18,925,368.65 | 11,737,008.34 | 7,761,054.6 |
| 归属于母公司股东的净利润 | -148,889,156.24 | 13,515,081.34 | 11,553,055.44 | 7,031,710.72 |
| 少数股东损益 | -11,934,659.23 | 5,410,287.31 | 183,952.9 | 729,343.88 |
| (一)基本每股收益 | -0.18 | 0.02 | 0.01 | 0.01 |
| (二)稀释每股收益 | -0.17 | 0.02 | 0.01 | 0.01 |
| 八、其他综合收益 | 967,814.67 | -1,145,162.82 | -7,105,328.76 | -11,033,374.73 |
| 归属于母公司股东的其他综合收益 | 526,764.08 | -7,030,727.02 | -7,043,639.88 | 12,319,483.13 |
| 九、综合收益总额 | -159,856,000.8 | 17,780,205.83 | 4,631,679.58 | -3,322,320.13 |
| 归属于母公司股东的综合收益总额 | -148,362,392.16 | 6,484,354.32 | 4,509,415.56 | 19,351,193.85 |
| 归属于少数股东的综合收益总额 | -11,493,608.64 | 11,295,851.51 | 122,264.02 | -22,623,513.97 |
| 公告日期 | 2024-04-23 | 2023-10-31 | 2023-08-29 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | | | |